April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Combination vs monotherapy for management of myelofibrosis
Sep 24, 2024, 16:24

Combination vs monotherapy for management of myelofibrosis

Talha Badar posted on X:

“Interesting debate on combination vs monotherapy for management of myelofibrosis.

Efficacy vs tolerability vs disease modification.

Dr. Adam Mead and Dr. Florian Heidel.”

Combination vs monotherapy for management of myelofibrosis

Source: Talha Badar/X

Dr. Talha Badar, MD, is a specialist in Hematology Oncology based in Mayo Clinic, Jacksonville, Florida. His primary areas of expertise include Leukemia, particularly Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Acute Lymphoblastic Leukemia (ALL), and Bone Marrow Transplantation. Over his career, he has actively contributed to clinical research and clinical trials.